Akava Therapeutics
Winnetka
About Akava Therapeutics
Akava Therapeutics is a small molecule therapeutics that inhibits protein aggregation, enzymes, and cancer for neurodegenerative diseases. The company was founded in 2019 by Richard Silverman and is headquartered in Winnetka, Illinois.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.3M
- Last round: Grant (Dec 2024)
- Website: akavatx.com
- Phone: 847-494-7434
Industries & Categories
Health Care, Medical, Therapeutics
Canonical: https://fsome.com/organization/akava-therapeutics-137159 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.